RLYB
Rallybio Corporation Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Rallybio (RLYB) Stock: Buy, Sell, or Hold?
$15.80
+0.04 (+0.25%)
▲
5d:
-0.63%
30d:
-5.5%
90d:
-6.84%
QUANTITATIVE VERDICT
BUY
HIGH Confidence (84%)
Quality Score
61/100
Position
SLIGHTLY LOW
30-Day Fair Range
$15.77 – $16.81
Position: SLIGHTLY LOW
Forward P/E & Valuation
-4.4x
Next 12M consensus est.
Wall Street Target
$8.00
-49.4% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$15.28 / $16.43
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
✅ BUY SIGNAL: RLYB shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Get Alerted When RLYB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: RLYB is currently trading at $15.80, which is considered slightly low relative to its 30-day fair value range of $15.77 to $16.81.
Technical Outlook: Technically, RLYB is in a uptrend. Immediate support is located at $15.28, while resistance sits at $16.43.
Market Sentiment: RLYB scores 81/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $8.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RLYB is in a uptrend. Immediate support is located at $15.28, while resistance sits at $16.43.
Market Sentiment: RLYB scores 81/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. However, the stock is trading significantly above the average Wall Street target of $8.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$15.77 -
$16.81
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
84.2%
Trading Range & Key Levels
30-Day Trading Range
$15.77 -
$16.81
Current vs Trading Range
SLIGHTLY LOW
Support Level
$15.28
Resistance Level
$16.43
Current Trend
Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (81/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 49.4% above Wall St target ($8.00)
- BULLISH: Bottoming setup score 81/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-4.39
Wall Street Target
$8.00
(-49.4%)
Profit Margin
6177.4%
Share RLYB Analysis
Share this live RLYB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (RLYB)
Neutral
3 Retail Mentions
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Jun 1, 2026
Daily AI digest
AI Retail Discussion Summary:
Rallybio Corporation and Avenzo Therapeutics announce a merger agreement and a $215 million private placement to advance oncology therapies, sparking bullish sentiment on StockTwits.
Key Retail Themes:
Oncology therapies
Merger and acquisition
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:50 PM ET
Data refreshes hourly during market hours. Next update: 9:50 PM
Data refreshes hourly during market hours. Next update: 9:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RLYB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 61 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 37 SELL |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 63 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive RLYB Research Pages
